Currency Economy

Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infection

Coronavirus (Mar 11, 2021 06:55AM ET) Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infection

© Reuters. Pfizer logo in Manhattan, New York

(Reuters) – Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) said on Wednesday that real-world data from Israel suggests that their COVID-19 vaccine is 94% effective in preventing asymptomatic infections, meaning the vaccine could significantly reduce transmission.

The companies also said the latest analysis of the Israeli data shows the vaccine was 97% effective in preventing symptomatic disease, severe disease and death. That is basically in line with the 95% efficacy Pfizer and BioNTech reported from the vaccine’s late-stage clinical trial in December.

According to the analysis, unvaccinated individuals were 44 times more likely to develop symptomatic COVID-19 and 29 times more likely to die from COVID-19 than those who had received the vaccine.

The data, collected between Jan. 17 and March 6, has not yet been peer reviewed.Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infection Add a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s